HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prop 65 “safe use determinations

This article was originally published in The Rose Sheet

Executive Summary

" California Office of Environmental Health Hazard Assessment planning July 1 public hearing in Sacramento on amendments to regulations governing the process by which businesses can request the assurance and advice of the office regarding product compliance with Prop 65. Known as a safe use determination, the process so far has not been widely used in part due to concern that an SUD request may invite service of a 60-day notice of violation on the requester by a private party. Among the changes being considered, OEHHA would allow for the continuation of an SUD process as long as the request was accepted before service of a 60-day notice...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010324

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel